NRBO - NeuroBo Pharmaceuticals Inc
IEX Last Trade
3.68
0.170 4.620%
Share volume: 2,459
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.51
0.17
4.84%
Summary score
22%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.8%
Return on assets
-36.17%
Return on sales
0%
Return on invested capital
127.17%
Total debt ratio
48.47%
Debt ratio change over timeo
-0.55%
Current Ratio
3.84%
Quick Ratio
0%
Cash Position Ratio
3.64%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.72%
Return on assets
-19.28%
Return on sales
0%
Return on invested capital
88.29%
Total debt ratio
24.32%
Debt ratio change over timeo
-0.74%
Current Ratio
4.22%
Quick Ratio
0%
Cash Position Ratio
3.99%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-32.13%
Return on assets
-23.19%
Return on sales
0%
Return on invested capital
92.13%
Total debt ratio
27.97%
Debt ratio change over time
-0.67%
Current Ratio
3.57%
Quick Ratio
0%
Cash Position Ratio
3.42%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-143.78%
Return on assets
-135.26%
Return on sales
0%
Return on invested capital
34.39%
Total debt ratio
-54.86%
Debt ratio change over time
-0.55%
Current Ratio
2.58%
Quick Ratio
0%
Cash Position Ratio
2.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NRBO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -36.8% | -3.65% | 12.3% | 6.42% |
| Return on assets | -36.17% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 127.17% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 48.47% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.55% | 224.03% | 6.03% | 1.46% |
| Dept financing | 12% | 50% | 19% | 8% |
| Current Ratio | 4.22% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 3.99% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 25% | 52% | 57% |
| Short-term ratios | NRBO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.72% | -16.17% | 18.05% | 7.63% |
| Return on assets | -19.28% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 88.29% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 36% | 69% | 66% |
| Total debt ratio | 24.32% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.74% | 851.68% | 10.97% | 0.58% |
| Dept financing | 6% | 50% | 21% | 8% |
| Current Ratio | 4.22% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 3.99% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 38% | 29% | 54% |